Köpf-Maier P, Hesse B, Köpf H
J Cancer Res Clin Oncol. 1980 Jan;96(1):43-51. doi: 10.1007/BF00412896.
The antitumor activity of the metallocene dichlorides TDC, ZDC, and HDC against Ehrlich ascites tumor in CF1 mice is investigated. A single i.p. injection of TDC in the optimum dose (30-60 mg/kg) 24 h p.t.t. achieves survival of 80-90% of the animals until day 180 p.t.t. without any tumor manifestation. This indicates an increase in the mean survival time of about 900% referred to the untreated animals. In contrast, ZDC and HDC exhibit no recognizable antineoplastic properties under equal experimental conditions. Assuming a similar mechanism of tumor inhibition for both DDP and the antineoplastic active metallocene dichlorides TDC, VDC, and MDC the comparatively increased non bonding Cl...Cl distance ("bite") of ZDC and HDC may be responsible for cancerostatic inactivity of the latter compounds.
研究了二氯茂金属TDC、ZDC和HDC对CF1小鼠艾氏腹水瘤的抗肿瘤活性。在接种肿瘤后24小时腹腔注射一次最佳剂量(30 - 60毫克/千克)的TDC,直至接种肿瘤后180天,80 - 90%的动物存活且无任何肿瘤表现。这表明与未治疗的动物相比,平均存活时间增加了约900%。相比之下,在相同实验条件下,ZDC和HDC没有表现出可识别的抗肿瘤特性。假设顺铂(DDP)和抗肿瘤活性二氯茂金属TDC、VDC和MDC的肿瘤抑制机制相似,ZDC和HDC相对增加的非键合Cl...Cl距离(“间距”)可能是后两种化合物抗癌活性缺失的原因。